ARCHIVES

Wyden Hearing On Taxol Agreements Mangles Facts In Attempt To Protect ‘Public Interest’

This article is from The Cancer Letter archive.

Vol. 17 No. 32 | August 9, 1991

Download PDF Visit The Full Archive

Related Articles

Drug Approvals; Zykadia Granted Accelerated Approval For ALK+ NSCLC; ADXS-HPV Grated Orphan Drug Designation

May 9, 2014

NCAB Approves Call For New Efforts In Black/Hispanic Cancer

February 6, 1981

Ralph Yarborough, Senator Who Initiated National Cancer Act, Dead at 92

February 2, 1996

Bristol-Myers Adds UCLA, Fox Chase To Grants Program

April 12, 1985

Funding Opportunities Listed.

January 14, 2005

NCI Plans $30 Million In Patient-Oriented Chemoprevention research In Next 5 Years

December 6, 1996